MediTox s.r.o.

Main activities

Preclinical research and development in the field of cardiovascular disorders, neurodegenerative diseases, diabetes, vaccine development
Comprehensive preclinical and toxicological service for human and veterinary pharmaceuticals, biological drugs, medical devices (PHARMA), food additives and chemicals and chemical preparations (REACH)
Animal models of selected human diseases (cardiovascular, neurodegenerative, diabetes, ophthalmic, …)
Animal breeding – accredited breeding facility (Rodents, dogs, non-human primates)
Registration number: 104984/2010-17210

MediTox s.r.o.

MediTox s.r.o. is a GLP-certified preclinical contract research organization offering a wide range of preclinical development services taking advantage of wealth of experience in variety of therapeutics areas, biotechnology, chemical and agrochemical industry and research collaboration with universities and research institutions.


MediTox R&D activities are pointed to collaborative scientific and research projects within international and national framework.


The strong points of MediTox ensure personalized and comprehensive contract research (one-stop-shop), high professional standard together with, flexibility and competitive pricing.



International Congress BIOTECHNOLOGY – BIOTECH WORLD 2013, March 19 – 22, Moscow, Russia

International Congress BIOTEHNOLOGY

BIO International Convention 2013, April 22 – 25, Chicago, USA

BIO International Convention 2013

BioMed 2013, June 10 – 12, Tel Aviv, Israel

BioMed 2013

MediTox s.r.o.

zavřít

MediTox s.r.o.

zavřít

MediTox s.r.o.

zavřít